Shicong Tang, MD, Yunnan Cancer Hospital, China
Cancer Cell International is calling for submissions to our Collection on Novel Biomarkers and Cellular Mechanisms in Breast Cancer: Insights from In Vitro and In Vivo Single-Cell Studies.
Image credit: © VOISIN / PHANIE / Science Photo Library
This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.
Breast cancer research has significantly advanced in understanding cellular mechanisms and identifying crucial biomarkers for diagnosis, prognosis, and treatment. Further exploration is necessary to delve into the complexities of breast cancer progression, metastasis, and treatment responses. This collection will showcase pioneering research utilizing single-cell transcriptomics to reveal novel biomarkers and elucidate cellular mechanisms underpinning breast cancer progression and treatment responses. The studies will encompass both in vitro and in vivo research, focusing on metabolic and immunological heterogeneity within the tumour microenvironment. Additionally, it seeks to explore how these insights can be translated into potential therapeutic targets and predictive markers for the efficacy of immunotherapy and chemotherapy, thereby bridging the gap between laboratory findings and clinical strategies.
The collection scope includes, but is not limited to, the following topics:
• Biomarker identification and validation
• Tumour heterogeneity in breast cancer
• Signalling pathways and molecular mechanisms
• In vitro and in vivo models for breast cancer research
• Single-cell analysis and its implications
• Therapeutic targets and personalized medicine.
There are currently no articles in this collection.
This Collection welcomes submission of original Research and Review articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Novel Biomarkers and Cellular Mechanisms in Breast Cancer: Insights from In Vitro and In Vivo Single-Cell Studies" under the “Details” tab during the submission stage.
Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.